National Bank of Canada
RDHL

National Bank of Canada’s Redhill Biopharma RDHL Stock Holding History

National Bank of Canada’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-43
Closed -$1.26K – 2869
2023
Q2 		$1.26K Hold
43
– – ﹤0.01% 2527
2023
Q1 		$4.39K Hold
43
– – ﹤0.01% 2324
2022
Q4 		$6.02K Hold
43
– – ﹤0.01% 2287
2022
Q3 		$22K Hold
43
– – ﹤0.01% 1989
2022
Q2 		$37K Hold
43
– – ﹤0.01% 1851
2022
Q1 		$108K Hold
43
– – ﹤0.01% 1643
2021
Q4 		$111K Buy
+43
New +$172K ﹤0.01% 1605

Other funds holding RDHL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $6.06B AUM 28.9% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

National Bank of Canada's RDHL Position: Q3 2023 in Review

National Bank of Canada sold out of Redhill Biopharma (RDHL) in Q3 2023, closing a stake of 43 shares — an estimated $1.26K sold.

National Bank of Canada first reported a position in RDHL in Q4 2021 and held it in 7 quarters. The position peaked at $111K in Q4 2021. 17 funds tracked by Wall St. Rank hold RDHL as of Q3 2023.

  • National Bank of Canada reported no remaining Redhill Biopharma position as of Q3 2023 after selling out during the quarter.
  • National Bank of Canada sold 43 Redhill Biopharma shares in Q3 2023, an estimated $1.26K.
  • National Bank of Canada first reported a position in Redhill Biopharma in Q4 2021 and held it in 7 quarters.
  • National Bank of Canada's Redhill Biopharma position peaked at $111K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2023.

Based on National Bank of Canada's 13F filing for Q3 2023, filed 10 Oct 2023.